Growth Inhibitors

"Growth Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS).

Descriptor ID	D006131
MeSH Number(s)	D27.505.696.377.450
Concept/Terms	Growth Inhibitors Growth Inhibitors Inhibitors, Growth Cell Growth Inhibitors Growth Inhibitors, Cell Inhibitors, Cell Growth

Below are MeSH descriptors whose meaning is more general than "Growth Inhibitors".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Growth Substances [D27.505.696.377]
Growth Inhibitors [D27.505.696.377.450]

Below are MeSH descriptors whose meaning is related to "Growth Inhibitors".

Below are MeSH descriptors whose meaning is more specific than "Growth Inhibitors".

Growth Inhibitors
Angiogenesis Inhibitors

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Growth Inhibitors" by people in this website by year, and whether "Growth Inhibitors" was a major or minor topic of these publications.

Bar chart showing 23 publications over 14 distinct years, with a maximum of 3 publications in 2001

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	2	0	2
1998	1	1	2
2000	0	1	1
2001	3	0	3
2002	2	0	2
2004	2	0	2
2005	1	1	2
2006	1	0	1
2009	0	1	1
2010	0	1	1
2011	1	1	2
2012	0	2	2
2014	1	0	1
2023	0	1	1

Below are the most recent publications written about "Growth Inhibitors" by people in Profiles.

Ingle K, LaComb JF, Graves LM, Baines AT, Bialkowska AB. AUM302, a novel triple kinase PIM/PI3K/mTOR inhibitor, is a potent in vitro pancreatic cancer growth inhibitor. PLoS One. 2023; 18(11):e0294065.

View in: PubMed
Klaus CR, Iwanowicz D, Johnston D, Campbell CA, Smith JJ, Moyer MP, Copeland RA, Olhava EJ, Scott MP, Pollock RM, Daigle SR, Raimondi A. DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells. J Pharmacol Exp Ther. 2014 Sep; 350(3):646-56.

View in: PubMed
Strong N, Millena AC, Walker L, Chaudhary J, Khan SA. Inhibitor of differentiation 1 (Id1) and Id3 proteins play different roles in TGF? effects on cell proliferation and migration in prostate cancer cells. Prostate. 2013 May; 73(6):624-33.

View in: PubMed
Rangwala F, Williams KP, Smith GR, Thomas Z, Allensworth JL, Lyerly HK, Diehl AM, Morse MA, Devi GR. Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines. BMC Cancer. 2012 Sep 10; 12:402.

View in: PubMed
Chattopadhyay M, Kodela R, Nath N, Dastagirzada YM, Vel?zquez-Mart?nez CA, Boring D, Kashfi K. Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol. 2012 Mar 15; 83(6):715-22.

View in: PubMed
Martins M, Lazzell AL, Lopez-Ribot JL, Henriques M, Oliveira R. Effect of exogenous administration of Candida albicans autoregulatory alcohols in a murine model of hematogenously disseminated candidiasis. J Basic Microbiol. 2012 Aug; 52(4):487-91.

View in: PubMed
Nath N, Chattopadhyay M, Pospishil L, Cieciura LZ, Goswami S, Kodela R, Saavedra JE, Keefer LK, Kashfi K. JS-K, a nitric oxide-releasing prodrug, modulates ?-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism. Biochem Pharmacol. 2010 Dec 01; 80(11):1641-9.

View in: PubMed
Maniccia AW, Lewis C, Begum N, Xu J, Cui J, Chipitsyna G, Aysola K, Reddy V, Bhat G, Fujimura Y, Henderson B, Reddy ES, Rao VN. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins. J Cell Physiol. 2009 Jun; 219(3):634-41.

View in: PubMed
Perez-Torres M, Guix M, Gonzalez A, Arteaga CL. Epidermal growth factor receptor (EGFR) antibody down-regulates mutant receptors and inhibits tumors expressing EGFR mutations. J Biol Chem. 2006 Dec 29; 281(52):40183-92.

View in: PubMed
Patisaul HB, Fortino AE, Polston EK. Neonatal genistein or bisphenol-A exposure alters sexual differentiation of the AVPV. Neurotoxicol Teratol. 2006 Jan-Feb; 28(1):111-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals